2009Internal Medicine of ChinaRequires access

Therapeutic effect of trilogy eradicates helicobacter pylori infection with esomeprazole,levofloxacin and amoxicillin

LI Cong-yi

Open publisher page 1 citations

Abstract

Objective To study therapeutic effect and safety trilogy treatment of esomeprazole,levofloxacin and amoxicillin on helicobacter pylori infection (Hp).Methods 116 cases of positive chronic gastritis and peptic ulcer were randomly into two groups.Patients in treatment group were treated with one-week trilogy of esomeprazole,levofloxacin add amoxicillin twice a day.Patients in control group were treated with esomeprazole and Clarithromycin and cont twice a day for a week.The two groups had been rechecked five weeks treatment later to observe the eradication rate of Hp,clinical symptoms and side effect.Results The eradication rate of Hp was 91.4% vs 87.9% in treatment group and control group.There is no obvious difference between two group (P0.05).Clinical symptoms and adverse effect of the treatment group were less than the control group.Conclusion The one-week trilogy treatment of esomeprazole,levofloxacin and amoxicillin is ideal protocol for the treatment of Hp infection.

About this research paper

What this paper is about

Objective To study therapeutic effect and safety trilogy treatment of esomeprazole,levofloxacin and amoxicillin on helicobacter pylori infection (Hp).Methods 116 cases of positive chronic gastritis and peptic ulcer were randomly into two groups.Patients in treatment group were treated with one-week trilogy of esomeprazole,levofloxacin add amoxicillin twice a day.Patients in control group were treated with esomeprazole and Clarithromycin and cont twice a day for a week.The two groups had been rechecked five weeks treatment later to observe the eradication rate of Hp,clinical symptoms and side effect.Results The eradication rate of Hp was 91.4% vs 87.9% in treatment group and control group.There is no obvious difference between two group (P0.05).Clinical symptoms and adverse effect of the treatment group were less than the control group.Conclusion The one-week trilogy treatment of esomeprazole,levofloxacin and amoxicillin is ideal protocol for the treatment of Hp infection.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study therapeutic effect and safety trilogy treatment of esomeprazole,levofloxacin and amoxicillin on helicobacter pylori infection (Hp).Methods 116 cases of positive chronic gastritis and peptic ulcer were randomly into two groups.Patients in treatment group were treated with one-week trilogy of esomeprazole,levofloxacin add amoxicillin twice a day.Patients in control group were treated with esomeprazole and Clarithromycin and cont twice a day for a week.The two groups had been rechecked five weeks treatment later to observe the eradication rate of Hp,clinical symptoms and side effect.Results The eradication rate of Hp was 91.4% vs 87.9% in treatment group and control group.There is no obvious difference between two group (P0.05).Clinical symptoms and adverse effect of the treatment group were less than the control group.Conclusion The one-week trilogy treatment of esomeprazole,levofloxacin and amoxicillin is ideal protocol for the treatment of Hp infection.

Key concepts: Esomeprazole, Levofloxacin, Amoxicillin, Medicine, Gastroenterology, Helicobacter pylori, Clarithromycin, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effect of trilogy eradicates helicobacter pylori infection with esomeprazole,levofloxacin and amoxicillin — Research Paper | ScholarLens